Anna M. Bastiaansen

Rotterdam, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Muscle Regeneration Failure May Lead to Clinical Features of Myopathy in Anti-IgLON5 Disease.

Muscle Regeneration Failure May Lead to Clinical Features of Myopathy in Anti-IgLON5 Disease.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: July 13, 2026

Clinical Manifestations, Tumor Associations, and Long-Term Outcomes of Anti-KLHL11 Encephalitis.

Clinical Manifestations, Tumor Associations, and Long-Term Outcomes of Anti-KLHL11 Encephalitis.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: May 29, 2026

Autoimmune Encephalitis as Treatment-Responsive Cause of Rapidly Progressive Dementia: A Multicenter Prospective Cohort Study.

Autoimmune Encephalitis as Treatment-Responsive Cause of Rapidly Progressive Dementia: A Multicenter Prospective Cohort Study.

Journal: Neurology

Published: May 15, 2026

Early Recognition of Treatment-Responsive Rapidly Progressive Dementia: The Modified STAM3mP Score.

Early Recognition of Treatment-Responsive Rapidly Progressive Dementia: The Modified STAM3mP Score.

Journal: Annals of clinical and translational neurology

Published: April 15, 2026

A new Patient-Reported Outcome Scale to assess autoimmune Encephalitis: PROSE.

A new Patient-Reported Outcome Scale to assess autoimmune Encephalitis: PROSE.

Journal: Annals of neurology

Published: December 05, 2025

A new Patient-Reported Outcome Scale to assess autoimmune Encephalitis: PROSE.

A new Patient-Reported Outcome Scale to assess autoimmune Encephalitis: PROSE.

Journal: Annals of neurology

Published: December 05, 2025

Movement Disorders in Antibody-Associated Neurologic Diseases: A Nationwide Study.

Movement Disorders in Antibody-Associated Neurologic Diseases: A Nationwide Study.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: November 21, 2025

Development and validation of the NEOS2 score for prediction of long-term outcomes and improvement after first-line immunotherapy in patients with anti-NMDAR encephalitis: an international cohort study.

Development and validation of the NEOS2 score for prediction of long-term outcomes and improvement after first-line immunotherapy in patients with anti-NMDAR encephalitis: an international cohort study.

Journal: The Lancet regional health. Europe

Published: July 24, 2025

Long-Term Cognitive, Functional, and Patient-Reported Outcomes in Patients With Anti-NMDAR Encephalitis.

Long-Term Cognitive, Functional, and Patient-Reported Outcomes in Patients With Anti-NMDAR Encephalitis.

Journal: Neurology

Published: November 20, 2024

Autoimmune Encephalitis and Paraneoplastic Neurologic Syndromes: A Nationwide Study on Epidemiology and Antibody Testing Performance.

Autoimmune Encephalitis and Paraneoplastic Neurologic Syndromes: A Nationwide Study on Epidemiology and Antibody Testing Performance.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: October 28, 2024

Antibodies Associated With Autoimmune Encephalitis in Patients With Presumed Neurodegenerative Dementia.

Antibodies Associated With Autoimmune Encephalitis in Patients With Presumed Neurodegenerative Dementia.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: December 08, 2022

Predictive Value of Serum Neurofilament Light Chain Levels in Anti-NMDA Receptor Encephalitis.

Predictive Value of Serum Neurofilament Light Chain Levels in Anti-NMDA Receptor Encephalitis.

Journal: Neurology

Published: June 30, 2022

Showing 1-12 of 22

Last Updated: 09/26/2026